Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

US9951372B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9951372-B2
Application numberUS-201314032420-A
CountryUS
Kind codeB2
Filing dateSep 20, 2013
Priority dateSep 2, 2011
Publication dateApr 24, 2018
Grant dateApr 24, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides compounds and methods for assaying redox state of metabolically active cells and methods for assaying enzyme activity and/or metabolite level by coupling to redox defining co-factor NAD(P)/NAD(P)H measurement.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for detecting cellular metabolites in a sample comprising, a. contacting the sample with a compound of formula (II), (III), or (IV), a dehydrogenase amplification enzyme system, NAD or NADP, a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate, and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 2. The method of claim 1 , wherein the compound, dehydrogenase amplification enzyme, diaphorase, NAD or NADP and luciferase reaction mixture are in a single composition. 3. A method of detecting NADH or NADPH in a sample comprising: a. contacting the sample with a compound of formula (II), (III), or (IV), a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 4. The method of claim 3 , wherein the sample is further contacted with a diaphorase inhibitor. 5. The method of claim 3 , wherein the compound, diaphorase and luciferase reaction mixture are in a single composition. 6. A method of determining total NAD(P)/NAD(P)H in a sample comprising: a. contacting the sample with a dehydrogenase amplification enzyme system, a compound of formula (II), (III) or (IV), a diaphorase that utilizes NADH or NADPH as a co-factor and the compound of formula (II), (III), or (IV) as a diaphorase substrate, and a luciferase reaction mixture; and b. detecting bioluminescence; wherein the compound of formula (II) is wherein R 1 is H, C 1-4 alkyl, C 1-4 hydroxylalkyl, C 3-7 cyclic ring, aryl, benzyl or substituted benzyl ring, heterocycle, heteroaryl or —(CH 2 ) n′ —P(Ph) 3 ; R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; and n′ is an integer from 2-7; the compound of formula (III) is wherein R 4 and R 5 are independently selected from H, halogen, methyl, and trifluoromethyl; the compound of formula (IV) is wherein R 2 is —CH 2 -aryl or —CH 2 -heteroaryl; R 5 is —CH 2 -aryl or —CH 2 -heteroaryl; and R 7 is aryl or heteroaryl; wherein R 14 is H, C 1-4 alkyl, C 1-4 alkoxyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide; R 9 and R 10 are independently selected from C 1-4 alkyl; R 11 , R 12 and R 13 are independently selected from H, C 1-4 alkyl, C 1-4 alkoxyl, bromo, chloro or amino, or R 11 and R 12 can form a fused phenyl ring; X is O, NH or a direct bond; L is a direct bond or —C 6 (R 16 ) 4 CH 2 — or —(CH 2 ) m C(R 17 ) 2 (CH 2 ) n —Y—C(O)—; wherein at least one of X or L is not a direct bond when the compound has formula (II); R 16 is independently H, halogen, CH 3 , OCH 3 , or NO 2 ; R 17 is independently H, C 1-4 alkyl or both R 17 together can form an alkyl ring having from 3-7 carbons; m is an integer from 0-2; n is an integer from 0-2; Y is O or NR 15 ; and R 15 is H, C 1-4 alkyl, C 2-4 hydroxylalkyl, C 2-4 alkoxyl, C 2-4 carboxylic acid, or C 2-4 amide. 7. The method of claim 6 , wh

Assignees

Inventors

Classifications

  • with fluorescent label · CPC title

  • C12Q1/32Primary

    involving dehydrogenase · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • co-enzymes or co-factors, e.g. NAD or ATP · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9951372B2 cover?
The present invention provides compounds and methods for assaying redox state of metabolically active cells and methods for assaying enzyme activity and/or metabolite level by coupling to redox defining co-factor NAD(P)/NAD(P)H measurement.
Who is the assignee on this patent?
Promega Corp
What technology area does this patent fall under?
Primary CPC classification C12Q1/32. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).